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Edited by Horst FeldmannAbstract Lamins A, C and C2 are alternatively spliced
products of the LMNA gene; lamins A and C are expressed in
diﬀerentiated somatic cells, whereas lamin C2 is expressed in
germ cells. We have analyzed a segment of the ﬁrst intron of the
LMNA gene for cell-type-speciﬁc regulatory elements. We
identiﬁed a 420-bp fragment that increased promoter activity in
lamin A-expressing cells but repressed activity in undiﬀerentiated
cells. DNase I footprinting and electrophoretic mobility shift
assays revealed two binding motifs, footprinted region A (FPRA)
and FPRB. The hepatocyte nuclear factor-3b was bound to
FPRA only in somatic cell extracts and this motif had an
inhibitory eﬀect on promoter activity. The retinoic X receptor b,
RXRb, bound near FPRB with extracts from lamin A- or C2-
expressing cells, and this site enhanced promoter activity. We
have, thus, identiﬁed two novel binding sites for transcription
factors in a region likely to function as an important regulatory
element for the cell-type-speciﬁc transcription of A-type lamins.
 2004 Published by Elsevier B.V. on behalf of the Federation of
European Biochemical Societies.
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The lamins are components of the nuclear lamina, a ﬁla-
mentous network of proteins underlying the inner nuclear
membrane. The lamina is considered to be an important de-
terminant of interphase nuclear architecture [1–3], and is in-
volved in the spatial organization of nuclear processes such as
DNA replication, transcription and RNA splicing [4–7]. Two
major kinds of lamins are present in higher vertebrates. The B-
type lamins (B1 and B2) are found in nearly all somatic cells,
whereas the A-type lamins (A and C) are expressed primarily
in diﬀerentiated cells, in a tissue- and stage-speciﬁc manner.
However, certain cells such as those of the hemopoietic lineage
do not express lamins A and C. Lamins A and C are alter-
natively spliced products of the LMNA gene, whereas lamins
B1 and B2 are coded by separate genes. Germ cells contain
additional splice variants of the lamin A and B2 genes termed* Corresponding author. Fax: +91-40-27160311/+91-40-27160591.
E-mail address: veenap@ccmb.res.in (V.K. Parnaik).
Abbreviations: EMSA, electrophoretic mobility shift assay; HNF-3b,
hepatocyte nuclear factor-3b; HFH-1, HNF-3/Fkh homolog 1; NFY,
nuclear factor Y; RAR, retinoic acid receptor; RXR, retinoic X
receptor; USF, upstream stimulatory factor
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doi:10.1016/j.febslet.2004.05.019C2 and B3, respectively [8–10]. The diﬀerential regulation of
lamin expression in diﬀerent tissues has important implications
for lamin function, since mutations in the human LMNA gene
lead to complex disease phenotypes, mainly aﬀecting muscle,
cardiac, adipose and bone tissues, and also cause premature
ageing (reviewed in [11]).
The expression of the LMNA gene is primarily under tran-
scriptional control and is induced upon cell diﬀerentiation,
being undetectable in embryonic cells [12–14]. We have pre-
viously reported the characterization of the proximal promoter
of the rat LMNA gene which harbors two important motifs, a
GC box at )101, which can bind to Sp1/Sp3 transcription
factors, and an AP-1 binding motif at )7 [15–17]. The 50
ﬂanking sequences of the mouse and human LMNA genes are
highly homologous to the rat sequences, with total conserva-
tion of the GC box, TATA-box and AP-1 motif in all three
species [18,19].
The developmental regulation of the lamin A promoter is
likely to involve a complex series of events that occur in a cell-
type-speciﬁc manner, and would require speciﬁc regulatory
motifs such as enhancers and silencers, which might be situated
further upstream of the 2.2-kb region that has already been
analyzed. Regulatory elements might also be present in the
large ﬁrst intron (14 kb) of the gene, as observed with other
members of the intermediate ﬁlament superfamily [20]. The
ﬁrst intron of the lamin A locus harbors the transcription
initiation site for the male germ-cell-speciﬁc lamin C2 tran-
script, after 10 kb of intronic sequence [18], which is ex-
pressed in pachytene spermatocytes (PS) while lamin A and C
transcripts are downregulated during spermatogenesis [8,9].
Although the somatic and germ cell lamins have a diﬀerent
ﬁrst exon and are likely to be regulated by unique promoters,
lamins A, C and C2 share the exons 2–9. Lamin A has distinct
exons 10–12 due to 30 alternate splicing.
As an initial approach towards understanding the cell-type-
speciﬁc regulation of the rat A-type lamin promoter, we have
analyzed a 1.5-kb segment upstream of the lamin C2 transla-
tion initiation site for regulatory elements by reporter gene
assays of deletion constructs of this region. We have delineated
a 420-bp fragment which enhances promoter activity in two
diﬀerentiated cell lines, but acts as a repressive element in an
undiﬀerentiated embryonal carcinoma cell line. DNase I
footprinting analysis revealed two protected regions: an AT-
rich fragment which harbored a binding site for hepatocyte
nuclear factor-3b (HNF-3b) from the winged helix family of
transcription factors and another fragment which displayed
interactions with the retinoic X receptor (RXR) family of
proteins (primarily RXRb) in electrophoretic mobility shiftation of European Biochemical Societies.
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ﬁrmed by mutational analysis.Fig. 1. Deletion analysis of the lamin C2 upstream region. The line
diagram depicts the lamin A genomic region spanning the ﬁrst exons
(Ex 1, 10) for lamins A/C and C2, and the common second exon (Ex 2),
and the positions of the 1.5-kb and 420-bp fragments corresponding to
the )1553/+4 and )444/)24 segments. The )178/)24 construct was
cloned downstream of the LUC gene in the pGL3-Promoter vector
(pGL3-P) in the forward ()178/)24FD) and reverse ()178/)24RD)
orientation. The )1553/+4 region was cloned upstream of the SV40
promoter (P) in the forward (1553FP) and reverse (1553RP) direction.
The )444/)24P, )444/)166P and )178/)24P constructs were cloned
upstream of the SV40 promoter. Transient transfections were carried
out in the indicated cell lines and LUC activities were measured. The
results represent the mean of at least three experiments (S.E.). Actual
values for pGL3-P (relative to pGL3-Basic) are 40.5 (CRL-1600), 80
(NIH 3T3) and 41 (PCC-4).2. Materials and methods
2.1. Plasmid constructs
A 452-bp fragment encompassing the upstream region of the lamin
C2 ﬁrst exon ()444 to +8, with the translation start site ATG num-
bered as +1) was ampliﬁed by PCR of rat genomic DNA, using
primers derived from the mouse sequence [18], and was found to have
90% identity with the mouse sequence. This fragment was then used as
a probe to obtain a larger clone of 1.5 kb from a lambda FIX II ge-
nomic library (Stratagene, La Jolla, CA). A 420-bp segment spanning
)444/)24 and shorter fragments of this 420-bp segment as well as the
1.5-kb region were subcloned into the pGL3-Promoter vector, up-
stream of the SV40 promoter or downstream of the luciferase (LUC)
reporter gene. Mutant constructs were made by PCR with the ap-
propriate mutant primers and veriﬁed by DNA sequence analysis.
2.2. Cell culture and DNA transfections
CRL-1600 rat hepatoma cells, NIH 3T3 mouse ﬁbroblasts and PCC-
4 mouse embryonal carcinoma cells were maintained in Dulbecco’s
modiﬁed Eagle’s medium supplemented with 10% fetal bovine serum.
Transfections of reporter plasmids and a b-galactosidase expression
vector (pCH110 for NIH 3T3 and PCC-4 cells and pCMVSPORT b-
gal for CRL-1600 cells) were carried out as described [15,17]. Cells
were lysed and aliquots were assayed for LUC activity using a kit from
Promega Corporation (Madison, Wisconsin) and for b-galactosidase
activity as described [21]. The values for LUC activity were normalized
to the b-galactosidase activity as an internal control. Each experiment
was repeated at least three times.
2.3. DNase I footprinting analysis
DNase I footprinting analysis was carried out with two overlapping
segments spanning )444 to )166 and )222 to +8, which were ampliﬁed
in separate PCRs using one end-labeled primer and one unlabeled
primer for each reaction, so as to provide fragments in which the sense
and antisense strands were exclusively labeled. Nuclear extracts of
CRL-1600, NIH 3T3 and PCC-4 cells were isolated as described [22].
Pachytene spermatocytes were obtained from rat testicular cells by
centrifugal elutriation by a standard procedure, spermatocyte nuclei
were isolated as described [23], and extracts were prepared as above.
Approximately 2 104 cpm (20 ng) of probe and 0–20 lg of nuclear
extract were incubated in a total volume of 40 ll of binding buﬀer
containing 10 mM Tris–HCl, pH 7.5, 1 mM MgCl2, 0.5 mM DTT,
50 mM NaCl, 4% glycerol and 50 lg/ml of poly(dI–dC)–poly(dI–dC),
for 30 min at ambient temperature. Then, 40 ll of 5 mM CaCl2,
10 mMMgCl2 and 0.3 U of DNase I were added. After 1 min at room
temperature, the reaction was stopped with 90 ll of stop solution
containing 20 mM NaCl, 30 mM EDTA, 1% SDS and 10 lg of yeast
tRNA. The DNA probe was then puriﬁed and analyzed on an 8%
sequencing gel. A Maxam-Gilbert A+G sequencing reaction [21] was
electrophoresed in parallel with the DNase I-treated probe to map the
location of the footprinted region.
2.4. Electrophoretic mobility shift assays
EMSAs were performed with nuclear extracts of CRL-1600, NIH
3T3 and PCC-4 cells, and labeled double-stranded oligonucleotides.
The synthetic oligonucleotides used are listed in Figs. 4A and 6A and
were made on an ABI 394 synthesizer. Consensus oligonucleotides for
known transcription factor binding sites corresponded to those avail-
able commercially (Santa Cruz Biotechnology, Santa Cruz, CA), ex-
cept as mentioned in Section 3. A typical binding reaction was carried
out with 10 000 cpm of probe (0.01 pmol) and 5 lg of nuclear extract in
20 ll buﬀer containing 10 mM Tris–HCl, pH 7.5, 1 mM MgCl2,
50 mM NaCl, 0.5 mM DTT, 4% glycerol and 50 lg/ml poly(dI–dC)–
poly(dI–dC) or poly(dA–dT)–poly(dA–dT) for 20 min at room tem-
perature. In competition experiments, 50–100-fold molar excess of
unlabeled competitor was preincubated with the extracts for 10 min at
room temperature before the labeled oligonucleotide was added. For
antibody incubation assays, 1 lg of antibody was added to the binding
reaction and incubated for 60 min at 4 C. HNF-3b antibody (clone
4C7) was from the Developmental Studies Hybridoma Bank, IowaCity, IA and Sp4 antibody (clone V-20) was from Santa Cruz
Biotechnology. Mouse monoclonal antibodies to RXRa, b and c were
a kind gift from Prof. Pierre Chambon (Institut de Genetique et de
Biologie Moleculaire et Cellulaire, Strasbourg, France). The complexes
were resolved in non-denaturing 6% polyacrylamide gels in 45 mM
Tris-borate, pH 8.3, 1 mM EDTA buﬀer and gels were autoradio-
graphed overnight at )70 C.3. Results
3.1. Identiﬁcation of regulatory region in the ﬁrst intron of
LMNA
The region upstream of the lamin C2 translation start site
was analyzed for the presence of regulatory elements. The
1.5-kb and 420-bp ()444/)24) genomic fragments were cloned
upstream of the SV40 promoter in the LUC reporter vector
pGL3-Promoter. Transient transfections were carried out in
three cell lines: CRL-1600 rat hepatoma and NIH 3T3 mouse
ﬁbroblast cells, which are examples of diﬀerentiated cell types
that express lamins A and C, and PCC-4 mouse embryonal
carcinoma cells which are undiﬀerentiated cells that do not
express lamins A and C. All values for LUC activity were
expressed as percentage of pGL3-Promoter vector which was
taken as 100 to calculate the extent of activation or repression
by the diﬀerent constructs. The actual values for the
pGL3-Promoter vector in the diﬀerent cell lines, expressed as
fold activation over the promoterless vector pGL3-Basic, are
given in the legend to Fig. 1. The 1.5-kb and 420-bp fragments
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cloned into the pGL3-Basic vector (data not shown).
The 420-bp fragment ()444/)24P construct) exhibited nearly
3-fold activation in CRL-1600 and NIH 3T3 cells. Deletions of
this fragment as well as the longer 1.5-kb construct gave lower
values of activation (1.5–2.0-fold) in these cells. On the other
hand, the trend with these constructs in PCC-4 cells was that of
repression of the SV40 promoter. The constructs )178/)24P,
)444/)166P and )444/)24P reduced SV40 promoter activity
by 30–50%, whereas the 1553RP clone reduced SV40 promoter
activity by about 70%, suggesting that the silencing activity
was orientation independent. When the )178/)24 fragment
was analyzed in a position downstream of the reporter gene, it
gave 1.5–2.0-fold activation in both orientations in all the cell
lines. A construct harboring the 1.5-kb fragment cloned
upstream of the lamin A/C promoter (inserted at )740 with
respect to the lamin A transcription initiation site) did not
exhibit any distinct regulatory eﬀects (data not shown).
3.2. DNase I footprinting of regulatory region
As the transfection experiments revealed cell-type-speciﬁc
diﬀerences in the regulatory activity of the lamin C2 upstream
region, DNase I footprinting experiments were carried out to
localize the elements that might be important for this activity
in the 420-bp segment. Overlapping probes spanning )444/
)166 and )222/+8 were assayed separately for protein binding.
Only the regions that showed distinct footprints are discussed
here. On analyzing the sense strand of probe )222/+8 for
protein binding, distinct protection was observed in the region
extending from )174 to )195 with nuclear extracts from all the
three cell lines as shown in Fig. 2A. The antisense strand of this
region gave protection from )201 to )174 (data not shown).
The protected segment from )201 to )174 was referred to as
FPRA (for footprinted region A). The region from )204 to
)172 is highly AT-rich, and there is a continuous AT stretchFig. 2. DNase I footprinting analysis of (A) sense strand and (B) an-
tisense strand of )222/+8 probe. Footprinting reactions were carried
out in the absence (C) or presence of increasing concentrations (5–20
lg) of nuclear extracts of the indicated cell lines and PS. An A+G
sequencing reaction was run alongside as a marker. The FPRA region
was protected in (A) and the FPRB region was protected in (B) (shown
by open boxes on the right side of the CRL-1600 footprints).from )201 to )179. Another protected region extending from
)66 to )62 was observed with CRL-160 and NIH 3T3 extracts
but not with PCC-4 extracts with the antisense strand of the
probe )222/+8 as shown in Fig. 2B. This region was referred to
as FPRB. FPRA and FPRB are indicated in the sequence of
the )444/+8 segment in Fig. 3. Pachytene spermatocyte ex-
tracts gave FPRB but there was negligible protection at
FPRA. Hence, distinct diﬀerences were observed in the DNase
I footprinted regions between lamin A-expressing and non-
expressing cells, as well as somatic and germ cells.
3.3. Binding interactions at FPRA
In order to study the DNA–protein interactions at the
footprinted regions and to localize the precise bases responsible
for protein binding, EMSAs were carried out using synthetic
oligonucleotides spanning the footprinted regions. Analysis of
the FPRA sequence by MatInspector and TFSEARCH yielded
putative consensus binding sites for the following transcription
factors (sites are indicated in Fig. 4A): HNF-3, site I/II, HNF-
3/Fkh homolog 1 (HFH-1, site I/II) and nuclear factor Y
(NFY, Y/CCAAT box binding factor, site III). To analyze this
region by EMSAs, a 41-bp oligonucleotide extending from
)207 to )168 was used. Since this oligonucleotide has a high
AT content (78%), poly(dA–dT)–poly(dA–dT) was used as the
non-speciﬁc competitor instead of poly(dI–dC)–poly(dI–dC) as
initial experiments with the latter had resulted in more non-
speciﬁc bands. Mutant oligonucleotides with mutations in the
above consensus sites were used in competitions with the wild-
type oligonucleotide at 100-fold molar excess. On incubating
CRL-1600, NIH 3T3 or PCC-4 nuclear extracts with the la-
beled 41-mer probe, one major complex was obtained which
was speciﬁc as it was competed out with 100-fold excess of
unlabeled probe (see Fig. 4B–D). Mutant oligonucleotides
AM1 and AM2, that have 2-bp mutations in site I, competed
for binding with the wild-type probe. An oligonucleotide with a
mutation in site III (AM3), which is a motif for the CCAAT
box, also competed for binding. Hence, sites I and III could be
ruled out as being important for complex formation. The mu-
tant oligonucleotide AM4 with mutations at )182 and )183 in
site II also competed; however, AM5, with mutations at )180
and )181 in site II did not compete with the wild-type probe at
100-fold excess. Hence, the residues )180 and )181 are im-
portant for forming the complex.
Further competition reactions were carried out with con-
sensus oligonucleotides for the above transcription factors.
The consensus HNF-3 sequence was based on a strong aﬃnity
HNF-3 site in the transthyretin promoter [24] and the HFH-1
sequence was based on the consensus binding sequence for
puriﬁed HFH-1 derived by Overdier et al. [25]. A consensusFig. 3. Sequence of lamin C2 upstream fragment from )448 to +13.
FPRA and FPRB are in bold. The lamin C2 transcription initiation
sites at )30 and )41 are shown by asterisks, while the ATG translation
initiation codon at +1 is in italics.
Fig. 4. EMSAs of the FPRA segment. The sequences listed are the
FPRA-containing oligonucleotide extending from )207 to )168 (wt,
FPRA in bold and sites I, II and III indicated), mutants (AM1–AM5,
mutated bases in lower case) and consensus oligonucleotides
(HNFCO, NFYCO and HFHCO, binding motifs in bold italics).
EMSAs were carried out with nuclear extracts from (B) CRL-1600, (C)
NIH 3T3, (D) PCC-4 and (E) PS, with the competitor oligonucleotides
(Comp) listed in (A) or with no competitor ()). The major speciﬁc
complex formed is indicated by an arrow. A non-speciﬁc band is
shown by an asterisk.
Fig. 5. EMSAs with the FPRA fragment with antibody preincubation.
EMSAs were carried out with labeled FPRA oligonucleotide and nu-
clear extracts from CRL-1600, NIH 3T3 and PCC-4 cells that had been
preincubated with HNF-3b or Sp4 antibodies. The immunodepleted
complex is marked by arrows. The amount of free probe (not shown)
was equivalent in all lanes.
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available sequence. The NFY consensus did not compete with
the wild-type probe, which was consistent with the results
obtained for competitions with the mutant oligonucleotides,
and suggested that the CCAAT box was unlikely to be in-
volved in complex formation. However, both HNF-3 and
HFH-1 consensus oligonucleotides competed with the wild-
type probe. As both these factors have overlapping speciﬁcities
[26], they can theoretically bind at site I or II. Since the
competition data with mutant oligonucleotides suggested that
site II was important for complex formation, it is likely that
the HNF-3/HFH-1 classes of transcription factors bind to site
II. No speciﬁc complex formation was observed with sper-
matocyte extracts (Fig. 4E), in keeping with the absence of a
footprint at FPRA with these extracts.
To identify the factor forming a complex at site II, EMSAs
were carried out in the presence of antibody to the candidatefactor HNF-3b [27] as well as Sp4 antibody as a non-speciﬁc
control. As shown in Fig. 5, the speciﬁc complex formed with
extracts from CRL-1600, NIH 3T3 and PCC-4 cells was de-
pleted with HNF-3b antibody but Sp4 antibody did not have
any eﬀect. This conﬁrms that the complex formed with FPRA
is composed of HNF-3b.
3.4. Binding interactions at FPRB
The footprinted region designated as FPRB was further
analyzed by EMSAs. A MatInspector search for transcription
factor sites in the )70/)45 region yielded two putative con-
sensus sites, one of which was a partial consensus for the
CANNTG motif that binds to upstream stimulating factor
(USF) and the other was the consensus site for the retinoic acid
receptor (RAR) family of transcription activators. A 26-mer
double-stranded oligonucleotide extending from )70 to )45
was assayed for protein binding using nuclear extracts from
CRL-1600, NIH 3T3 and PCC-4 cell lines, as well as PS ex-
tracts. Consensus oligonucleotides containing the binding sites
for USF, RAR or RXR were used as competitors. The RAR
oligonucleotide has 5 bp between the two direct repeats re-
quired for binding, whereas the RXR oligonucleotide has 1 bp.
With CRL-1600 and NIH 3T3 extracts, one major complex
‘a’ was observed which was speciﬁc and showed a similar
pattern of competitions with mutant oligonucleotides (Fig. 6).
A minor complex ‘b’ showing similar behavior with mutant
competitors as complex ‘a’ was faintly detectable. Also a minor
non-speciﬁc band was detectable just above the major complex
‘a’. Oligonucleotides containing mutations in the footprinted
region or the USF binding site (BM1-4) competed for the
formation of complexes ‘a’ and ‘b’. BM6, carrying a 6-bp
mutation in bases upstream of BM5, also competed for com-
plexes ‘a’ and ‘b’. Hence, these sequences were not involved in
the formation of the complexes. On the other hand, BM5
which had mutations in the bases )59 to )54 did not compete
for binding. Thus, this sequence is likely to be important for
complex formation. A reexamination of the footprint in this
region indicated that this sequence did not get digested eﬃ-
ciently by DNase I even in the absence of nuclear extracts, and
hence was not scored as a protected region. Competition ex-
Fig. 7. EMSAs with the FPRB fragment with antibody preincubation.
EMSAs were carried out with labeled FPRB oligonucleotide and nu-
clear extracts from CRL-1600, NIH 3T3, PS and PCC-4 cells that had
been preincubated with RARa, b, c or Sp4 antibodies. Immunode-
pleted complexes are marked by arrows. The amount of free probe (not
shown) was equivalent in all lanes.
Fig. 6. EMSAs of the FPRB segment. The sequences listed are the
FPRB-containing oligonucleotide extending from )70 to )45 (wt,
FPRB in bold), mutants (BM1-6, mutated bases in lower case) and
consensus oligonucleotides (USFCO, RARCO and RXRCO, binding
motifs in bold italics). EMSAs were carried out with nuclear extracts
from (B) CRL-1600, (C) NIH 3T3, (D) PCC-4 and (E) PS, with the
competitor oligonucleotides (Comp) listed in (A), or with no com-
petitor ()). The major speciﬁc complexes ‘a’ and ‘b’ are marked by
arrows. Non-speciﬁc bands are shown by asterisks.
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tides for USF, RAR and RXR. Competition with 100-fold
excess of RAR and RXR oligonucleotides but not USF oli-
gonucleotide abolished complexes ‘a’ and ‘b’. Hence, com-
plexes ‘a’ and ‘b’ are likely to be formed due to binding of a
member of the RAR family. Complex formation with sper-
matocyte extracts was similar to that observed with CRL-1600
and NIH 3T3 extracts.
A diﬀerent pattern of complex formation was observed with
PCC-4 extract. Complex ‘b’ was the major complex formed,
whereas complex ‘a’ could not be detected. The competition
patterns with the mutant oligonucleotides of both the bands
were identical to those observed for CRL-1600 and NIH 3T3
extracts. Also, the competition patterns with the consensus
oligonucleotides for USF, RAR and RXR were similar.
However, a non-speciﬁc band between ‘a’ and ‘b’ was more
intense in PCC-4 extracts. Only this non-speciﬁc band between
‘a’ and ‘b’ was competed out by the USF consensus oligonu-
cleotide, suggesting that this band might be formed due to low
aﬃnity binding of USF to the CANNTG motif in the )70/)45oligonucleotide, whereas USF may bind with high aﬃnity to
its consensus oligonucleotide. The increased intensity of the
complex might be due to a higher amount of USF in PCC-4
cells. A strong non-speciﬁc complex was observed just below
the wells of the gel in several batches of PCC-4 extracts but its
origin could not be ascertained. These data suggest that there
are diﬀerences in the composition of the complexes formed in
lamin A-expressing and non-expressing cell types, though both
are likely to involve members of the RAR/RXR families of
transcription factors.
To identify the factors binding to this site, EMSAs were
carried out with preincubation with speciﬁc antibodies. As the
short distance between the RAR/RXR half-sites in the FPRB
region was more similar to that for the RXR consensus, these
assays were carried out with antibodies to the RXR family of
transcription factors, speciﬁcally RXRa, b and c [28] as well as
Sp4 as a negative control. Antibodies to RXRb depleted the
complex formed with extracts from CRL-1600 and NIH 3T3
cells and PS as shown in Fig. 7. Depletion was also observed
with antibody to RXRa with NIH 3T3 extract. However, these
antibodies did not aﬀect the complex obtained with PCC-4
extracts.
3.5. Functional analysis of mutant constructs
To ascertain the functional signiﬁcance of the sequences
identiﬁed to be important by DNase I footprinting and EM-
SAs, deletion- and mutant-reporter gene constructs were made
and assayed by transient transfections. As the )178/)24P
P. Arora et al. / FEBS Letters 568 (2004) 122–128 127construct, which had been analyzed by transient transfections,
did not contain the AT-rich FPRA region, a longer clone
containing this sequence (from )220 to )24) was obtained by
PCR and cloned into pGL3-Promoter vector, to give the )220/
)24P construct. This was resorted to as PCR-based muta-
genesis of the AT-rich FPRA segment was unlikely to succeed.
To analyze the segments identiﬁed to be important in protein
binding to the FPRB region, PCR-based site-directed muta-
genesis of the )444/)24 clone was carried out with the BM4
and BM5 mutant oligonucleotides (by inverse PCR) and the
mutated sequences were cloned into pGL3-Promoter. Se-
quence analysis indicated that in )444/)24BM5P, the wild-
type sequence encompassing the downstream RXR half site,
GGTCAC was mutated to TTCTCT. In )444/)24BM4’P, the
wild-type sequence containing the upstream RXR half-site,
GTCACA was mutated to GTCTC. The LUC activities of the
control plasmid (pGL3-Promoter) and the above constructs
were analyzed by transfection into CRL-1600, NIH 3T3 and
PCC-4 cell lines (Fig. 8).
FPRA analysis. In CRL-1600 cells, activation by the )220/
)24P construct (1.2-fold) was less than with )178/)24P (2.2-Fig. 8. Functional analysis of FPRA and FPRB segments. The indi-
cated constructs were transfected into CRL-1600, NIH 3T3 and PCC-4
cells, and LUC activities were measured. The results represent the
mean of at least three experiments (S.E.). A summary of the com-
parative activities is shown; the ‘a’ and ‘b’ sets of constructs were used
for the analysis of FPRA (*) and FPRB (OO, a mutated half site is
shown as OX or XO), respectively.fold). Similar results were obtained with NIH 3T3 cells (1.3
and 1.8-fold). In PCC-4 cells, where the 50 region of C2 shows
general repression, the trend was similar though lower in
magnitude. Hence, in all the three cell lines the addition of the
AT-rich region has a repressive eﬀect. This raises the possi-
bility that there is an activation motif between )220 and )444.
However, this has not been examined further as a distinct
footprint was not obtained in this region.
FPRB analysis. Compared to the 3.2-fold activation exhib-
ited by the wild-type )444/)24P construct in CRL-1600 cells,
the )444/)24M5P mutant construct showed only 2.0-fold ac-
tivation of the SV40 promoter. The mutant construct )444/
)24M4’P, on the other hand, activated the promoter to a
similar extent as the wild-type construct. Similar results were
obtained with NIH 3T3 cells. Hence, with both these cell lines,
mutation of the downstream RXR site reduced activation
levels, indicating that this motif acts as an activator. A similar
though smaller eﬀect was observed in PCC-4 cells.4. Discussion
We have identiﬁed a 420-bp segment in the ﬁrst intron of the
lamin A gene with cell-type-speciﬁc regulatory activity. This
segment enhanced activity in diﬀerentiated cells that express
lamins A/C, increasing SV40 promoter activity by almost 3-
fold in hepatoma and ﬁbroblast cell lines. On the other hand,
in the embryonal carcinoma cell line PCC-4, which does not
express A-type lamins, this 420-bp fragment downregulated
SV40 promoter activity.
Two major protected regions were identiﬁed in the 420-bp
fragment by DNase I footprinting analysis. FPRA was pro-
tected by nuclear extracts from CRL-1600, NIH 3T3 and PCC-
4 cells but not by PS extracts. FPRA contains consensus sites
for binding of proteins belonging to the HNF-3/fkh homolog
family (also termed the winged helix or forkhead box/Fox
family) that includes at least 20 proteins in rodents [29].
Winged helix proteins are important regulators of cellular
diﬀerentiation and metabolism, and act as transcriptional ac-
tivators as well as repressors. The target binding site for the
winged helix family of transcription factors is AT-rich and has
the 7-bp recognition motif 50 (G/A)(T/C)(C/A)AA(C/T)A. The
bases ﬂanking this motif contribute to the binding speciﬁcity of
various members of the family [25,26]. In EMSAs, a speciﬁc
complex was formed by CRL-1600, NIH 3T3 and PCC-4 ex-
tracts but not by PS extracts. The binding site for the complex
was narrowed down to site II, which is a consensus sequence
for binding of HNF-3 or HFH-1 classes of transcription fac-
tors. EMSAs with a speciﬁc antibody indicated that HNF-3b
was bound at this motif with extracts from CRL-1600, NIH
3T3 and PCC-4 cells. Functional analysis of this sequence
suggested that it had the properties of a repressor motif in all
three cell lines. The occupancy of this site by proteins from
somatic cells but not PS has important implications, since the
lamin C2 promoter is repressed or inactive in somatic cells.
In EMSAs of the FPRB-containing oligonucleotide with
CRL-1600, NIH 3T3 and PS extracts, a major complex ‘a’ was
formed at the sequence )59 to )54 downstream of FPRB. On
the other hand, in PCC-4 extracts complex ‘b’, which was of
slower mobility, was the major complex formed at this se-
quence. Both the complexes ‘a’ and ‘b’ were competed out by
128 P. Arora et al. / FEBS Letters 568 (2004) 122–128RAR and RXR oligonucleotides. Members of this nuclear
hormone receptor superfamily are known to be diﬀerentially
regulated during cellular diﬀerentiation [28,30]. Most members
of this family, including RAR and RXR, bind as homodimers
or heterodimers to direct/inverted/everted repeats of two half-
sites with the core motif RGGTCA. The spacing between the
two half-sites determines the speciﬁcity of binding [31]. In this
study, the complexes formed in EMSAs appeared to involve
the sequence from )59 to )54, that is a single half-site, and the
EMSA result was supported by the functional analysis of
the mutants. EMSAs with speciﬁc antibodies indicated that the
complexes from CRL-1600, NIH 3T3 and PS extracts were
primarily composed of RXRb with inclusion of RXRa in the
complex from NIH 3T3 cells. The complex formed in PCC-4
cells did not appear to be composed of RXRa, b or c proteins.
This could be due to the lower amounts of RXR factors in
undiﬀerentiated cells [28], or binding of other members of the
RAR/RXR families of factors. The possibility that this region is
a retinoic-acid responsive element has important implications,
since expression of lamins A and C is induced upon diﬀerenti-
ation and retinoic acid is a well known inducer of diﬀerentiation
and lamin A expression [32]. A GT-rich motif in the lamin A
proximal promoter, that can bind to the Sp1 family of tran-
scription factors [16], is also responsive to retinoic acid [33].
The presence of a regulatory region upstream of the lamin
C2 transcription initiation site (multiple sites mapped to )40,
)41 and )45 in the mouse [18], and to )30 and )41 in the rat,
our unpublished data) has interesting implications. As the
FPRA segment acts as a repressor in somatic cells, we suggest
that this segment can downregulate the lamin C2 promoter in
non-germ cell lineages. This would need to be analyzed in
transgenic mouse models, as a functional characterization of
the lamin C2 promoter has not been feasible in primary germ
cell cultures (our unpublished work). The FPRB regulatory
motif, which contains a RAR/RXR binding site, may be re-
quired to upregulate promoter activity upon embryonic cell
diﬀerentiation. The 1.5-kb segment did not alter lamin A
promoter activity although we cannot rule out an eﬀect on the
lamin A promoter by other intronic sequences. An activating
domain has been reported within the ﬁrst 3 kb of the intron,
which enhances promoter activity in a mammary carcinoma
cell line, but its functional motifs have not been analyzed [34].
The regulation of expression of the individual lamin isoforms,
which are splice variants, might also be exerted at the level of
transcript processing. Thus, this genomic locus is subject to
complex regulatory controls in diﬀerent cell types.
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